USP compounding and hazardous drugs: <795>, <797>, <800>, beyond-use dates, training, testing, records
3 free Uniform MPJE practice questions on this topic, with the answer, a reason for every option and the source. The full bank has 85 questions here.
A hospital names an experienced certified pharmacy technician as the designated person responsible for its hazardous drug program. According to USP <800>, this is:
- Anot allowed unless she is the pharmacist-in-charge
- Ballowed, because the designated person does not have to be a pharmacist
- Callowed only if a pharmacist co-signs every hazardous drug record she keeps
Show answer and sources
Answer: B. allowed, because the designated person does not have to be a pharmacist
Under USP <800>, the designated person does not have to be a pharmacist (USP <800> FAQs, FAQ 23). State rules may add requirements.
- A. Wrong: USP does not require the pharmacist-in-charge to be the designated person.
- B. Correct: USP <800> does not require a pharmacist.
- C. Wrong: USP sets no co-signature requirement.
According to USP <795>, a pharmacist starts compounding an oral suspension at 9:00 a.m. on June 1 and dispenses it on June 3. The beyond-use date is counted from:
- Athe time it was dispensed on June 3
- Bthe time the patient takes the first dose
- Cthe time compounding began on June 1
Show answer and sources
Answer: C. the time compounding began on June 1
A BUD is the date, or hour and date, after which a compounded preparation must not be used, counted from when preparation is initiated (USP <795> FAQs, FAQ 53).
- A. Wrong: the BUD is not counted from dispensing.
- B. Wrong: the BUD is not counted from first use.
- C. Correct: the BUD runs from the start of compounding.
A community pharmacy performs three tasks. According to USP <795>, which one is outside the scope of the chapter?
- AAdding flavoring to a commercial oral liquid
- BMaking a cream from bulk powder
- CSplitting a scored tablet in half
Show answer and sources
Answer: C. Splitting a scored tablet in half
Breaking or cutting a tablet is not subject to USP <795>, but adding flavoring to a manufactured product is compounding (USP <795> FAQs, FAQ 9 and FAQ 20).
- A. Wrong: flavoring a drug product is compounding.
- B. Wrong: preparing a cream from bulk powder is compounding.
- C. Correct: tablet splitting is outside <795>.
- [1] USP <795> FAQs (Pharmaceutical Compounding—Nonsterile Preparations) . FAQ 9; FAQ 20
Practise all 85 questions on this topic
Tutor mode, timed blocks and progress tracking.